Abstract:Background and aims: Concanavalin A (ConA) administration induces a rapid and severe liver injury in mice, and invariant natural killer T (iNKT) cells are recognized to be the key effector cells in this process. However, the underlying regulatory mechanisms are not well defined. Approach and results: We found that iNKT cells constitutively expressed TIPE2 (Tumor necrosis factor-α-induced protein 8-like 2, or TNFAIPL2). Genetic TIPE2 ablation strongly sensitized mice to ConA-induced hepatitis, accompanied with hyperactivation of iNKT cells. Moreover, Tipe2-/- mice were also more susceptible to α-galactosylceramide (αGalCer)-induced liver injury, with elevated serum ALT level and enhanced proinflammatory cytokine production. CD1d signaling blockade or iNKT cell elimination through antibodies reduced the effect of TIPE2 deficiency on liver injury. Mechanistic studies revealed that TIPE2 in iNKT cells functioned as a negative regulator, limiting iNKT cell activity and cytokine production through PIP3- AKT/mTOR pathway. TIPE2-mediated protection from liver injury was further validated by the administration of adeno-associated viruses expressing TIPE2, which effectively ameliorated ConA-induced hepatic injury. However, TIPE2 was dispensable in two other liver injury models, including D-GalN/LPS and APAP-induced hepatitis. Conclusion: Our findings reveal a new role of TIPE2 in the attenuation of iNKT cell-mediated hepatic injury. We propose that TIPE2 serves as an important regulator of immune homeostasis in the liver, and might be exploited for the therapeutic treatment of autoimmune liver diseases.

Crystal structure of TIPE2 provides insights into immune homeostasis

Modulation of TET2 expression and 5-methylcytosine oxidation by the CXXC domain protein IDAX

Tissue-specific expression of TIPE2 provides insights into its function.

Structural insight into TIPE1 functioning as a lipid transfer protein

Research progress of TIPE2 in immune-related diseases

TIPE2 serves as a molecular switch of phagocytosis during infection

Tumor Necrosis Factor--Induced Protein 8-Like 2 Negatively Regulates Innate Immunity Against RNA Virus by Targeting RIG-I in Macrophages

TIPE2 Serves As a Molecular Switch of Phagocytosis During Infection (37.12)

Crystal Structure of Type Vi Effector Tse1 from Pseudomonas Aeruginosa

Crystal Structure of PXY-TDIF Complex Reveals a Conserved Recognition Mechanism among CLE Peptide-Receptor Pairs

Epithelial TIPE1 Protein Guards against Colitis by Inhibiting TNF-α-Mediated Inflammation

Crystal Structure and Functional Analysis of DEAD-box Protein Dhh1p.

Structure of the CABIT2 domain of THEMIS reveals a novel protein fold with an inserted SH3-like domain

The TIPE (TNFAIP8) family in inflammation, immunity, and cancer

TIPE2 controls innate immunity to RNA by targeting the phosphatidylinositol 3-kinase-Rac pathway.

Solution structure of Kti11p from Saccharomyces cerevisiae reveals a novel zinc-binding module.

TIPE2 Governs Macrophage Polarization Via Negative Regulation of Mtorc1

Crystal Structure of Pseudomonas Aeruginosa Tsi2 Reveals a Stably Folded Superhelical Antitoxin.

Tipe2 Protein Serves As A Negative Regulator of Phagocytosis and Oxidative Burst During Infection

Structure of the Type VI Effector-Immunity Complex (Tae4-Tai4) Provides Novel Insights into the Inhibition Mechanism of the Effector by Its Immunity Protein,

TIPE2 protein restrains invariant NKT activation and protects against immune-mediated hepatitis in mice